The Pharma Letter19h
Recce Pharma reports positive Phase II trial of RECCE 327 Gel
Australia’s Recce Pharmaceuticals has announced positive data from a Phase II trial evaluating RECCE 327 Topical Gel (R327G) ...
FierceBiotech21h
Australian biotech points to potential superbug use as gel treats skin infections in phase 2 trial
Recce Pharmaceuticals’ synthetic gel successfully treated a range of skin infections in a phase 2 trial, leading the ...